A detailed history of Royal London Asset Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Royal London Asset Management LTD holds 722,369 shares of LLY stock, worth $555 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
722,369
Previous 785,350 8.02%
Holding current value
$555 Million
Previous $711 Million 9.99%
% of portfolio
1.62%
Previous 1.85%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $48.6 Million - $60.5 Million
-62,981 Reduced 8.02%
722,369 $640 Million
Q2 2024

Aug 07, 2024

SELL
$724.87 - $909.04 $46.6 Million - $58.4 Million
-64,296 Reduced 7.57%
785,350 $711 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $24 Million - $32.1 Million
-40,555 Reduced 4.56%
849,646 $661 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $8 Million - $9.43 Million
-15,231 Reduced 1.68%
890,201 $519 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $157 Million - $216 Million
-361,200 Reduced 28.52%
905,432 $486 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $38.9 Million - $52.1 Million
111,000 Added 9.61%
1,266,632 $594 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $21.3 Million - $25 Million
68,611 Added 6.31%
1,155,632 $397 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $54.4 Million - $63.3 Million
169,047 Added 18.42%
1,087,021 $398 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $6.2 Million - $7.07 Million
-20,915 Reduced 2.23%
917,974 $297 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $28.6 Million - $33.5 Million
102,433 Added 12.25%
938,889 $305 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $4.35 Million - $5.4 Million
18,522 Added 2.26%
836,456 $240 Million
Q4 2021

Oct 18, 2022

BUY
$224.85 - $279.04 $2.2 Million - $2.72 Million
9,765 Added 1.21%
817,934 $226 Million
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $2.2 Million - $2.72 Million
9,765 Added 1.21%
817,934 $226 Million
Q3 2021

Oct 18, 2022

SELL
$221.6 - $272.71 $21.4 Million - $26.3 Million
-96,492 Reduced 10.67%
808,169 $187 Million
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $21.4 Million - $26.3 Million
-96,492 Reduced 10.67%
808,169 $187 Million
Q2 2021

Oct 18, 2022

SELL
$180.55 - $233.54 $6.18 Million - $7.99 Million
-34,228 Reduced 3.65%
904,661 $208 Million
Q2 2021

Jul 14, 2021

BUY
$180.55 - $233.54 $5.01 Million - $6.48 Million
27,756 Added 3.17%
904,661 $209 Million
Q1 2021

Oct 17, 2022

SELL
$164.32 - $212.72 $10.2 Million - $13.2 Million
-61,984 Reduced 6.6%
876,905 $164 Million
Q1 2021

Apr 13, 2021

BUY
$164.32 - $212.72 $4.52 Million - $5.85 Million
27,483 Added 3.24%
876,905 $164 Million
Q4 2020

Jan 29, 2021

BUY
$130.46 - $172.63 $2.91 Million - $3.85 Million
22,280 Added 2.69%
849,422 $143 Million
Q3 2020

Nov 04, 2020

BUY
$146.22 - $169.13 $21.1 Million - $24.4 Million
144,349 Added 21.14%
827,142 $121 Million
Q2 2020

Jul 31, 2020

SELL
$136.42 - $164.18 $1.99 Million - $2.39 Million
-14,564 Reduced 2.09%
682,793 $111 Million
Q1 2020

May 01, 2020

BUY
$119.05 - $147.35 $90,835 - $112,428
763 Added 0.11%
697,357 $96.5 Million
Q4 2019

Feb 05, 2020

BUY
$106.92 - $132.43 $1.57 Million - $1.95 Million
14,720 Added 2.16%
696,594 $91.5 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $300,720 - $327,106
2,816 Added 0.41%
681,874 $76.2 Million
Q2 2019

Jul 31, 2019

BUY
$110.79 - $129.32 $3.53 Million - $4.12 Million
31,832 Added 4.92%
679,058 $75.2 Million
Q1 2019

Apr 30, 2019

SELL
$111.31 - $131.02 $2.78 Million - $3.27 Million
-24,934 Reduced 3.71%
647,226 $0
Q4 2018

Jan 29, 2019

BUY
$105.9 - $118.64 $16.3 Million - $18.3 Million
154,323 Added 29.8%
672,160 $76.8 Million
Q3 2018

Nov 08, 2018

SELL
$85.86 - $107.31 $619,737 - $774,563
-7,218 Reduced 1.37%
517,837 $0
Q2 2018

Sep 19, 2018

BUY
$75.7 - $86.88 $39.7 Million - $45.6 Million
525,055 New
525,055 $44.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.